Rise of the selective inhibitors of anti-apoptotic Bcl-2 family proteins.
No trivial pursuit! It is not trivial to develop effective small-molecule regulators of protein-protein interactions (PPIs). Moreover, anti-apoptotic Bcl-2 family proteins share similar binding grooves, making it particularly difficult to target them selectively. Despite these challenges, potent and selective inhibitors of individual members of the Bcl-2 family have been successfully developed.